Phio Pharmaceuticals
PHIO
#10279
Rank
A$17.37 M
Marketcap
A$1.57
Share price
2.94%
Change (1 day)
-48.70%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -A$12.36 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$10.72 Million, an increase over its 2023 earnings that were of -A$16.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$12.36 Million15.35%
2024 -A$10.72 Million-33.96%
2023 -A$16.23 Million-5.7%
2022 -A$17.21 Million-13.6%
2021 -A$19.92 Million51.09%
2020 -A$13.18 Million-1.28%
2019 -A$13.35 Million21.03%
2018 -A$11.03 Million-53.1%
2017 -A$23.52 Million74.49%
2016 -A$13.48 Million-12.02%
2015 -A$15.33 Million16.17%
2014 -A$13.19 Million-57.95%
2013 -A$31.36 Million62.45%
2012 -A$19.31 Million0.87%
2011 -A$19.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.21 Million 128.29%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.24 Billion 1,905.27%๐Ÿ‡บ๐Ÿ‡ธ USA